Teleflex (NYSE:TFX) announced today that it released its new Arrow pressure injectable midline portfolio of catheters in North America. Wayne, Pennsylvania-based Teleflex designed its Arrow portfolio to help alleviate line identification confusion. The company said a lack of identification between midlines and catheters creates the potential for … [Read more...] about Teleflex launches new injectable midline catheter portfolio
teleflex
Teleflex’s central venous access catheters awarded Vizient supply contract
Teleflex today announced it was awarded a contract for the supply of central venous access devices from Vizient, effective immediately. The agreement allows Vizient members to take advantage of special pricing for Teleflex's line of central venous access catheters (CVCs). The group purchasing agreement includes Teleflex's Arrowg+ard Blue Plus … [Read more...] about Teleflex’s central venous access catheters awarded Vizient supply contract
Teleflex launches Arrow pressure catheter in New Zealand
Teleflex this week announced it launched its Arrow Pressure Injectable Midline catheter in Australia and New Zealand. The Wayne, Pennsylvania-based company designed Arrow to help clinicians overcome catheter identification confusion. The regional launch follows last week's announcement of the availability of the catheter in Europe, the Middle … [Read more...] about Teleflex launches Arrow pressure catheter in New Zealand
Teleflex launches Arrow Pressure Injectable Midline catheter in EMEA region
Teleflex today announced that it has launched its Arrow Pressure Injectable Midline catheter in Europe, the Middle East and Africa regions. Wayne, Pennsylvania-based Teleflex designed Arrow to help clinicians overcome catheter identification confusion. The new, 20 cm Arrow Pressure Injectable Midline is brightly colored with yellow hubs and … [Read more...] about Teleflex launches Arrow Pressure Injectable Midline catheter in EMEA region
Teleflex wins FDA clearance for expanded indications of CTO specialty catheters, guidewires
Teleflex (NYSE:TFX) today announced that it received FDA clearance for expanded indication for its specialty catheters and coronary guidewires for use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI). Devices that are included in the expanded indication are the Teleflex GuideLiner V3 catheter, TrapLiner catheter, … [Read more...] about Teleflex wins FDA clearance for expanded indications of CTO specialty catheters, guidewires
Teleflex recalls some Arrow-Trerotola over-the-wire PTD kits
Teleflex (NYSE:TFX) announced that it initiated a worldwide recall of its Arrow-Trerotola over-the-wire PTD (percutaneous thrombolytic device) kit. Wayne, Pennsylvania-based Teleflex designed the Arrow-Trerotola (PTD) catheter in conjunction with the Arrow rotator drive unit to allow for the mechanical declotting of the native arterio-venous … [Read more...] about Teleflex recalls some Arrow-Trerotola over-the-wire PTD kits
4 catheter-based devices to watch for in 2021
Medical device companies are working to gain regulatory approvals and launch new catheter-based devices as the world slowly returns to normal after reeling from the COVID-19 pandemic. As of April 19, the FDA had approved 11 medical devices this year — two of them catheter-based. In comparison, the regulatory agency approved 19 devices by April … [Read more...] about 4 catheter-based devices to watch for in 2021
The worst catheter-based device recalls of 2020
The U.S. saw nine serious medical device recalls related to catheters in 2020 — up from four the previous year, according to the FDA. The agency 2020 tagged a total of 33 medical device recalls as Class I — the most serious level — down from 49 in 2019. The list of the most serious catheter-based device recalls in 2020 includes products from … [Read more...] about The worst catheter-based device recalls of 2020
Teleflex wins FDA clearance for EZ-IO intraosseous vascular access system expanded indications
Teleflex today said it received FDA 510(k) clearance for expanded indications of its Arrow EZ-IO intraosseous vascular access system. The device is designed to be used when intravenous access is difficult or impossible to obtain in emergent, urgent or medically necessary cases. The expanded indication allows the device to be used for up to 48 … [Read more...] about Teleflex wins FDA clearance for EZ-IO intraosseous vascular access system expanded indications
Vascular Solutions recall of Langston dual lumen catheter is Class I
The FDA issued a notice today warning that its recall of the Vascular Solutions Langston dual lumen catheter is identified as Class I, the most serious kind of recall. Vascular Solutions, a Teleflex (NYSE:TFX) subsidiary, designed the Langston dual lumen catheter for the rapid delivery of dye into blood vessels during medical imaging tests, … [Read more...] about Vascular Solutions recall of Langston dual lumen catheter is Class I
